Douglas S McCorkle - VP Controller and Asst Treasur, Regeneron Pharmaceuticals Inc

As of December 29, 2015


Douglas S McCorkle Net Worth

  • Net worth is estimated to be at least $31.16M
  • Owns at least 10,995 units of Regeneron Pharmaceuticals Inc stock
  • Sold an estimated value of $31.45M in the last 8 years at Regeneron Pharmaceuticals Inc

Douglas S McCorkle Trading

  • Largest purchase of shares was 13,464 units , worth over $2.34M on May 26, 2015
  • Largest sale of shares was 13,000 units , worth over $6.7M on May 26, 2015
  • In total has made about 31 transactions over 8 years
  • Usually trades in December, with the busiest year in 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Douglas S McCorkle Mailing Address

  • Mailing address is Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 NY

Regeneron Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

Regeneron Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 1,000 units sold on January 5, 2022 by Marion McCourt worth over $625K
  • In the last 19 years, insiders at Regeneron Pharmaceuticals Inc sold an estimated value of $17.1B and bought an estimated value of $3.34B
  • The most active traders are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director
  • Insider trading is most common in December, with the busiest year in 2014

REGENERON PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1